Scratching, rubbing, chewing, licking. All signs of an irritated, itchy dog. With approximately 17 million U.S. dogs ...

A newly published study compared clinical outcomes of Zenrelia and another leading JAK inhibitor, plus the latest faces of ...

ELAN's robust pipeline and strategic acquisitions position it well for future growth, despite current setbacks with Zenrelia. Compared to Zoetis, Elanco appears significantly undervalued ...

Elanco's recent trajectory has been marked by significant developments in its product portfolio. The company received approval for Zenrelia QD, a treatment for canine atopic dermatitis ...

This optimism is supported by the increasing adoption of Zenrelia among U.S. veterinarians, indicating a potential to capture a significant market share, which could contribute to Elanco achieving ...

Hunter, Trooper, Scrappy and Buckaroo find zen by using Zenrelia <li /> Newly published study in a leading peer-reviewed, ...

Today, Elanco Animal Health Incorporated (NYSE:ELAN), is introducing some of the first allergic dogs who have found zen and gotten back to normal by using Zenrelia. Zenrelia, which was approved by ...

In fact, a newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, described the findings of a randomized, clinical trial which compared Zenrelia to the ...

Veterinarians in the U.S. can learn more and place orders for Zenrelia now at ZenreliaForVets.com. Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to ...

Today, Elanco Animal Health Incorporated (NYSE: ELAN), is introducing some of the first allergic dogs who have found zen and gotten back to normal by using Zenrelia. Zenrelia, which was approved by ...